Search

everythinglearnresearchcommunity

for

Search:↓

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Older people at home often have skin issues, but there's little evidence on how to prevent or treat them effectively.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

A woman and her daughter had thallium poisoning from a herbal drink and rodenticide, causing hair loss and other symptoms.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Cancer survivors need better skin care to improve their quality of life.

Stem cell therapy shows promise for treating skin disorders.

Blacks and Hispanics have higher chances of alopecia areata than Whites.

Skin conditions can cause significant psychological distress, so addressing mental health is crucial for improving quality of life.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Korean patients with rosacea are more likely to have other health conditions.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Various treatments exist for hair loss, but more research is needed for better options.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Metformin shows promise for treating skin conditions, but more research is needed.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.